Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zsolt Lengyel

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 23, 2019
Comparison of different motion correction techniques for dynamic FDG-PET/CT studies in breast cancer patientsTímea TŐkÉs, Magdolna Dank, Zsolt Lengyel, et al.
Neurology India|April 5, 2005
Does increased 18FDG uptake reflect malignant transformation of a low-grade glioma? A diagnostic dilemmaLaszlo Novak, Peter Molnar, Zsolt Lengyel, et al.
Clinical Nuclear Medicine|October 25, 2013
Port-site metastasis after laparoscopic removal of an isolated adrenal metastasis in a patient with breast cancer detected with FDG PET/CTKornélia Kajáry, Péter Molnár, Zsolt Lengyel, et al.
Magyar Onkologia|May 26, 2012
[The role of PET-CT in detecting unknown primary tumour in patients with cervical lymph node metastases]Miklós Fülöp, Miklós Kásler, Eva Remenár, et al.
Pathology Oncology Research : POR|July 15, 2020
Metabolic Parameters as Predictors for Progression Free and Overall Survival of Patients with Metastatic Colorectal CancerZsuzsanna Nemeth, Wouter Wijker, Zsolt Lengyel, et al.
Orvosi Hetilap|February 4, 2014
[Is ceCT necessary beyond FDG-PET/CT for primary staging in Hodgkin lymphoma?]Kornélia Kajáry, Zsuzsa Molnár, Szabolcs Szakáll, et al.
Orvosi Hetilap|June 25, 2002
[Standard PET examination protocols]Zsolt Lengyel, Attila Fekésházy, Beáta Kálvin, et al.
Orvosi Hetilap|June 25, 2002
[Movement-activated [15O]-butanol PET scan in patients with Parkinson disease]István Valálik, Miklós Emri, Zsolt Lengyel, et al.
Magyar Onkologia|March 26, 2009
[The advantage of Positron Emission Tomography combined with Computer Tomography (PET-CT) in the diagnosis of lung cancer (experience with 408 patients)]Miklós Zsiray, Zsolt Markóczy, Melinda Magyar, et al.
Orvosi Hetilap|June 25, 2002
[Diagnostic possibilities of positron emission tomography in oncologic pulmonology]Attila Fekésházy, Tünde Miklovicz, Olga Esik, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 23, 2019
Comparison of different motion correction techniques for dynamic FDG-PET/CT studies in breast cancer patientsTímea TŐkÉs, Magdolna Dank, Zsolt Lengyel, et al.
Neurology India|April 5, 2005
Does increased 18FDG uptake reflect malignant transformation of a low-grade glioma? A diagnostic dilemmaLaszlo Novak, Peter Molnar, Zsolt Lengyel, et al.
Clinical Nuclear Medicine|October 25, 2013
Port-site metastasis after laparoscopic removal of an isolated adrenal metastasis in a patient with breast cancer detected with FDG PET/CTKornélia Kajáry, Péter Molnár, Zsolt Lengyel, et al.
Magyar Onkologia|May 26, 2012
[The role of PET-CT in detecting unknown primary tumour in patients with cervical lymph node metastases]Miklós Fülöp, Miklós Kásler, Eva Remenár, et al.
Pathology Oncology Research : POR|July 15, 2020
Metabolic Parameters as Predictors for Progression Free and Overall Survival of Patients with Metastatic Colorectal CancerZsuzsanna Nemeth, Wouter Wijker, Zsolt Lengyel, et al.
Orvosi Hetilap|February 4, 2014
[Is ceCT necessary beyond FDG-PET/CT for primary staging in Hodgkin lymphoma?]Kornélia Kajáry, Zsuzsa Molnár, Szabolcs Szakáll, et al.
Orvosi Hetilap|June 25, 2002
[Standard PET examination protocols]Zsolt Lengyel, Attila Fekésházy, Beáta Kálvin, et al.
Orvosi Hetilap|June 25, 2002
[Movement-activated [15O]-butanol PET scan in patients with Parkinson disease]István Valálik, Miklós Emri, Zsolt Lengyel, et al.
Magyar Onkologia|March 26, 2009
[The advantage of Positron Emission Tomography combined with Computer Tomography (PET-CT) in the diagnosis of lung cancer (experience with 408 patients)]Miklós Zsiray, Zsolt Markóczy, Melinda Magyar, et al.
Orvosi Hetilap|June 25, 2002
[Diagnostic possibilities of positron emission tomography in oncologic pulmonology]Attila Fekésházy, Tünde Miklovicz, Olga Esik, et al.
Pageof 6